Women's Health Research
An estimated 39 out of 100 women in the U.S. will develop cancer in their lifetime. The V Foundation is committed to funding game-changing research that improves prevention, detection, and treatment of cancers that disproportionately affect women, including breast, cervical, and ovarian cancers. Together, with the generous support of donors, we are making a lifesaving difference for women faced with these cancers.
The V Foundation has invested over $42.2 million in breast cancer research.
V Foundation funded researchers of breast cancer have worked on 188 clinical trials.
These scientists have received $8.38 billion in cancer research funding throughout their careers.
This investment has fueled innovations that have helped raise the five-year survival rate of breast cancer to 92%. But, there are more lives to be saved.
Clea Shearer Breast Cancer Research Fund
Clea Shearer, co-founder of The Home Edit, executive producer and personality on Netflix’s Emmy-nominated show Get Organized with The Home Edit, New York Times bestselling author, and influential tastemaker, discovered a lump during a self-exam and was diagnosed with stage 2 breast cancer. Determined to make an impact, she went public to share her journey and raise awareness. The Clea Shearer Breast Cancer Research Fund promotes early detection, access to screening services for all women, and advances research to save lives of other women.
Accelerating Cancer Vaccines
In partnership with the Cancer Vaccine Coalition (CVC), founded by survivor Kristen Dahlgren, we’re funding clinical trials for therapeutic breast cancer vaccines, an emerging and innovative targeted treatment option. The CVC has already raised over $2 million, with a goal of $3 million in grants awarded through the V Foundation.
Breast Cancer Awareness Month
Throughout Breast Cancer Awareness Month, we celebrate thrivers and team up with partners dedicated to making an impact in the fight against breast cancer. By joining us this month and all-year long, you help fund lifesaving cancer research treatments.
Screening and treatment advances have cut cervical cancer rates by more than 50% since the mid-1970s. Yet, cervical cancer remains the second leading cause of cancer death in women ages 20-39.
Our investment has empowered those researchers to receive an additional $4 billion in funding and work on 51 clinical trials.